Tuk Bert
Leiden Academic Center for Drug Research (LACDR), Leiden University, Leiden, 2333 CC, Netherlands; Ry Pharma, Hofstraat 1, Willemstad, 4797 AC, Netherlands.
F1000Res. 2016 Aug 2;5:1904. doi: 10.12688/f1000research.9318.1. eCollection 2016.
Based upon a review of published clinical observations regarding syphilitic amyotrophic lateral sclerosis (ALS), I hypothesize that syphilis is actually a confounding factor, not a causative factor, in syphilitic ALS. Moreover, I propose that the successful treatment of ALS symptoms in patients with syphilitic ALS using penicillin G and hydrocortisone is an indirect consequence of the treatment regimen and is not due to the treatment of syphilis. Specifically, I propose that the observed effect is due to the various pharmacological activities of penicillin G ( ., a GABA receptor antagonist) and/or the multifaceted pharmacological activity of hydrocortisone. The notion that syphilis may be a confounding factor in syphilitic ALS is highly relevant, as it suggests that treating ALS patients with penicillin G and hydrocortisone-regardless of whether they present with syphilitic ALS or non-syphilitic ALS-may be effective at treating this rapidly progressive, highly devastating disease.
基于对已发表的关于梅毒性肌萎缩侧索硬化症(ALS)临床观察的回顾,我推测梅毒实际上是梅毒性ALS中的一个混杂因素,而非致病因素。此外,我提出使用青霉素G和氢化可的松成功治疗梅毒性ALS患者的ALS症状是治疗方案的间接结果,并非由于梅毒得到了治疗。具体而言,我认为观察到的效果是由于青霉素G的各种药理活性(如,一种GABA受体拮抗剂)和/或氢化可的松的多方面药理活性。梅毒可能是梅毒性ALS中的一个混杂因素这一观点具有高度相关性,因为这表明用青霉素G和氢化可的松治疗ALS患者——无论他们患的是梅毒性ALS还是非梅毒性ALS——可能对治疗这种快速进展、极具破坏性的疾病有效。